GLG LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$4.15M Hold
49,173
0.3% 95
2017
Q3
$4.21M Sell
49,173
-4,572
-9% -$375K 0.27% 101
2017
Q2
$4.42M Sell
53,745
-9,747
-15% -$795K 0.27% 108
2017
Q1
$5.34M Buy
63,492
+9,137
+17% +$732K 0.29% 94
2016
Q4
$4M Sell
54,355
-1,530
-3% -$114K 0.28% 98
2016
Q3
$4.49M Sell
55,885
-3,597
-6% -$288K 0.32% 82
2016
Q2
$4.68M Sell
59,482
-4,059
-6% -$306K 0.35% 83
2016
Q1
$4.58M Buy
63,541
+5,341
+9% +$404K 0.29% 100
2015
Q4
$4.9M Buy
+58,200
New +$4.83M 0.29% 93
2015
Q3
Sell
-113,121
Closed -$9.44M 589
2015
Q2
$9.44M Sell
113,121
-435
-0.4% -$33.1K 0.2% 137
2015
Q1
$8.25M Buy
113,556
+351
+0.3% +$25K 0.24% 113
2014
Q4
$7.81M Hold
113,205
0.23% 124
2014
Q3
$7.34M Sell
113,205
-850
-0.7% -$53.8K 0.2% 156
2014
Q2
$7.09M Hold
114,055
0.21% 145
2014
Q1
$6.71M Buy
+114,055
New +$6.37M 0.23% 128

Other funds holding LLY

GLG LLC's LLY Position: Q4 2017 in Review

GLG LLC held its Eli Lilly (LLY) position steady in Q4 2017 at 49,173 shares worth $4.15M. The position accounts for 0.3% of the portfolio, ranked #95.

GLG LLC first reported a position in LLY in Q1 2014 and has held it in 15 quarters since. The position peaked at $9.44M in Q2 2015. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • GLG LLC held 49,173 shares of Eli Lilly worth $4.15M as of Q4 2017.
  • GLG LLC left its Eli Lilly share count unchanged in Q4 2017.
  • Eli Lilly made up 0.3% of GLG LLC's portfolio in Q4 2017, its #95 holding.
  • GLG LLC first reported a position in Eli Lilly in Q1 2014 and has held it in 15 quarters since.
  • GLG LLC's Eli Lilly position peaked at $9.44M in Q2 2015.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on GLG LLC's 13F filing for Q4 2017, filed 14 Feb 2018.